← BACK TO SEARCH RESULTS
Steven Ades, MD
Professor, Medicine-Hematology Oncology
Director, Clinical Trial Office
Cancer and Host Interactions (CHI)
Key Areas of Interest / Study
Bladder cancer, Coagulation and thrombosis/hemostasis in cancer patients, Colon cancer, Esophageal/stomach cancer, Liver/pancreatic cancer, Prostate cancer, Survivorship/supportive care
Academic Interests
My research focus is the intersection of thrombosis and cancer. I am the co-leader of a large cohort study of patients with advanced cancers who receive education, risk stratification and where applicable thromboprophylaxis at the UVMMC. Our team reports on multiple short and long term outcomes in this population as well as implementation research of this model in community oncology settings. I recently designed and activated a large phase III pragmatic cohort trial investigating different thrombo-prophylactic approaches for patients receiving systemic therapy at intermediate risk of developing VTE.
I am also hold an IND for a phase II trial investigating the impact of fezolinetant, a NK3R antagonist for moderate to severe hot flashes in men receiving androgen deprivation therapy for prostate cancer.
I am also hold an IND for a phase II trial investigating the impact of fezolinetant, a NK3R antagonist for moderate to severe hot flashes in men receiving androgen deprivation therapy for prostate cancer.
Awards, Honors, and Appointments
Member of the Alliance Clinical Trials in Oncology Symptom Intervention Committee
Member of the Alliance Clinical Trials in Oncology Genitourinary Committee
Member of the Alliance Clinical Trials in Oncology Rural Health Task Force
News Stories
Publications
To view more and/or the most recent publications by Steven Ades, please visit their bibliography.
-
Education
1992-1996 McGill University, Montreal, Canada; MD Medicine
1989-1992 McGill University, Montreal Canada; BS Chemistry
1989-1992 McGill University, Montreal Canada; BS Chemistry
Postdoctoral Training
2000-2002 Research Fellow, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, MA
2002-2005 Masters Degree in Epidemiology and Biostatistics, McGill University, Montreal, QC
1996-1999 Queens University postgraduate education in Internal Medicine (Kingston, Ontario)
1999-2002 Hematology/Oncology Fellowship, Tufts University, Boston MA
2002-2005 Masters Degree in Epidemiology and Biostatistics, McGill University, Montreal, QC
1996-1999 Queens University postgraduate education in Internal Medicine (Kingston, Ontario)
1999-2002 Hematology/Oncology Fellowship, Tufts University, Boston MA